Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 619-447-3 | CAS number: 99607-70-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Cloquintocet-mexyl technical has been evaluated for possible mutagenic activity in a range of assays including both in vitro and in vivo studies and covering a range of core endpoints (gene mutation, clastogenicity, DNA repair). The key studies are considered to be those for gene mutation in bacteria (Sokolowski 2010) and in mammalian cells (Dollenmeier 1987), and those for clastogenicity both in vitro (Ogorek 1998) and in vivo (Strasser 1987).
In vitro evaluation
The test substance was examined in four strains of S typhimurium (TA 1535, TA 1537, TA98 and TA100) and two strains of E coli (E. coli WP2 pKM 101 and E. coli WP2 uvr A pKM 101), in both the absence and presence of auxiliary metabolic activation (S9) (Sokolowski 2010). Cloquintocet-mexyl was negative in this assay. A negative result was also reported in an earlier supporting study on the same four Salmonella strains and E coli strain WP2 uvr A (Deparade 1990). the test substance was examined for gene mutation in mammalian cells using the HPRT locus in V79 cells, and at dose levels limited by toxicity in both the absence and presence of S9 (Dollenmeier 1987). Cloquintocet-mexyl was negative in this assay. The test substance was examined for clastogenic activity in CHO cells, again at dose levels limited by toxicity and solubility in both the absence and presence of S9 (Ogorek 1998). Cloquintocet-mexyl was negative in this assay. This finding confirmed an earlier supporting cytogenetic study using human lymphocytes (Strasser, 1987a). Negative results for Cloquintocet-mexyl were also obtained in supporting studies examining for the DNA repair endpoint in both rat hepatocytes (Hertner 1987) and human fibroblasts (Meyer, 1987).
Cloquintocet-mexyl has been thoroughly examined in a range of in vitro mutagenicity assays and shown to be negative.
The in vitro studies are summarised below. Key studies are shown in bold.
Study |
Concentrations/ Dose levels |
Results |
Reference |
Salmonella/E. coli in vitro |
0 to 5000 µg/plate, +/-activation |
negative |
Deparade, 1990 |
Salmonella/E. coli in vitro |
0 to 5000 µg/plate, +/-activation |
negative |
Sokolowski, 2010 |
Gene mutation in V79 cells in vitro |
0 to 250 µg/mL, - activation 0 to 500 µg/mL, + activation |
negative |
Dollenmeier, 1987 |
Cytogenetic test in human lymphocytes in vitro |
0 to 75 µg/mL, - activation 0 to 190 µg/mL, + activation |
negative |
Strasser, 1987 |
Cytogenetic test on Chinese hamster ovary cells in vitro |
0 to 25 µg/mL, - activation 0 to 50 µg/mL, + activation |
negative |
Ogorek, 1998 |
DNA repair in rat hepatocytes in vitro |
0 to 200 µg /ml |
negative |
Hertner, 1987 |
DNA repair in human fibroblasts in vitro |
0 to 60 µg/mL |
negative |
Meyer, 1987 |
In vivo evaluation
Cloquintocet-mexyl has been examined in the Chinese hamster bone marrow micronucleus assay, which can detect both clastogenic and aneugenic activity, in both male and female animals at doses up to 2500 mg/kg (Strasser, 1987). Cloquintocet-mexyl was negative in this assay.
Short description of key information:
The mutagenic potential of cloquintocet-mexyl has been assessed in a number of core genotoxicity assays in vivo and in vitro, covering a range of endpoints including gene mutation, DNA repair and clastogenicity. The data indicate that the test material is not genotoxic.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Cloquintocet-mexyl showed no evidence of genotoxicity in vitro or in vivo and does not warrant classification for this end point:
- under Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC, Annex VI, 4.2.2.
- under Regulation (EC) 1272/2008, Annex I, Part 3, 3.5.2.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.